Comparison
NMN vs Apigenin
NMN
Nicotinamide mononucleotide — NAD+ precursor. Studied for cellular aging and metabolic health.
Apigenin
Flavonoid found in chamomile, parsley, and celery. Popularized by Dr. Andrew Huberman for sleep and CD38 inhibition.
| Field | NMN | Apigenin |
|---|---|---|
| Category | neuroprotective | neuroprotective |
| Dose range | 250–1000mg | 50–100mg |
| Half-life | — | — |
| Onset | — | — |
| Evidence | EVIDENCEB | EVIDENCEB |
| Safety | ●●●●● | ●●●●● |
| Legal (US) | USOTC | USOTC |
| PubMed refs | 600 | 400 |
The comparison in plain English
Auto-generated from dataNMN and Apigenin are both in the neuroprotective category respectively. NMN Nicotinamide mononucleotide — NAD+ precursor. Apigenin Flavonoid found in chamomile, parsley, and celery.
Bottom line
NMN (evidence B, safety 5/5) matches the evidence base of Apigenin (evidence B, safety 5/5). NMN has the slightly cleaner safety profile. For users new to either, the higher-evidence option is the safer first try.
Choose NMN if
NMN is the better fit when your goal aligns with its mechanism (Direct precursor to NAD+ — one biosynthetic step closer than nicotinamide riboside, bypassing the NRK1/NRK2 enzymatic step) and the dose range (250–1000mg) suits your protocol. Half-life is —h.
Choose Apigenin if
Apigenin is the better fit when your goal aligns with its mechanism (Partial agonist at GABA-A receptors at the benzodiazepine binding site, producing mild anxiolytic and sleep-promoting effects without the dependence profile of pharmaceutical benzodiazepines) and the dose range (50–100mg) suits your protocol. Half-life is —h.